About UsFacilities

Focus on synthesis of complex API and its intermediates

  • Omgene is a Vadodara based R&D stage company engaged in development of lab-scale quantities of peptides, semi-synthetic & synthetic APIs and its intermediates
  • Expertise in synthesizing long peptide chains – up to 40 amino acid chains

Formulation R&D facility for complex generics

  • Qualified Scientists and Team Leaders to support development of Complex generics

GMP1 Commercial Manufacturing facility

Cleanroom facility within existing premises for supply of small volume API quantities: Initiated manufacturing of 8 peptide APIs and 2 semi synthetics API from August 2022 (FY23) FDA Approval is available.

  • Quality Assurance Facility
  • Quality Control Facility